Targeted agents for wall imaging

Emily A. Waters*, Thomas J. Meade

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

MRI is an increasingly important diagnostic tool for cardiovascular pathology, with the ability to assess ventricular wall motion, myocardial perfusion and viability, coronary artery disease, and the function of the cardiac valves. However, MR imaging is primarily used for diagnosis of functional abnormalities, which do not occur until relatively late in disease processes (often after irreversible tissue damage has occurred). Molecular imaging allows observation of disease processes as they occur, before functional abnormalities become apparent. Not only does it hold great promise for early and more accurate diagnoses but it also enables direct observation of therapeutic efficacy in individual patients, allowing optimization of the treatment regimen for each person. Furthermore, by allowing direct observation of physiological processes at the molecular level, molecular imaging enables longitudinal study of disease biochemistry.

Original languageEnglish (US)
Title of host publicationMagnetic Resonance Angiography
Subtitle of host publicationPrinciples and Applications
PublisherSpringer New York
Pages199-210
Number of pages12
ISBN (Electronic)9781441916860
ISBN (Print)9781441916853
DOIs
StatePublished - Jan 1 2012

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Targeted agents for wall imaging'. Together they form a unique fingerprint.

Cite this